Target intelligence / Profile preview

Disulfide bonds in mucin and bacterial biofilm extracellular matrix

Molecular classification
Extracellular matrix component, Chemical bond, Other
01

Overview

Disulfide bonds are critical covalent linkages that stabilize the three-dimensional structure of mucin glycoproteins and the extracellular polymeric substances (EPS) of bacterial biofilms (Thornton et al., 2008, PubMed). In the respiratory tract, these bonds cross-link mucin monomers into a dense, viscoelastic gel that traps pathogens; however, in diseases like cystic fibrosis and chronic obstructive pulmonary disease (COPD), excessive cross-linking leads to pathologically thick mucus (Fahy & Dickey, 2010, NEJM). Similarly, disulfide bonds within the biofilm matrix contribute to the structural integrity and antibiotic resistance of bacterial communities by anchoring proteins and polysaccharides (Zhao & Liu, 2010, PubMed). Therapeutic intervention typically involves thiol-containing reducing agents, such as N-acetylcysteine (NAC), which break these bonds through thiol-disulfide exchange (StatPearls, 2023). This process reduces the viscosity of mucus, facilitating mucociliary clearance, and destabilizes biofilms to enhance the penetration and efficacy of co-administered antibiotics (Olofsson et al., 2003, Applied and Environmental Microbiology). Targeting these chemical bonds remains a cornerstone strategy for managing obstructive airway diseases and persistent microbial infections.

Other names
Mucin disulfide cross-linksBiofilm matrix disulfide bondsThiol-disulfide exchange targetsMucus disulfide bonds
02

Mechanism of action

Thiol-disulfide exchange reaction resulting in the reduction of covalent disulfide cross-links into free sulfhydryl groups, causing depolymerization of the macromolecular matrix (StatPearls, 2023).

03

Biological functions

Structural integrityViscoelasticity regulationPathogen entrapmentBiofilm stabilityOther
04

Disease associations

InfectionInflammationCystic fibrosisChronic obstructive pulmonary diseaseBronchitisOther
05

Safety considerations

BronchospasmMucosal irritationSulfurous odorDisruption of protective mucus layers
06

Interacting drugs

N-acetylcysteine

5 more in the full profile.

07

Biomarkers

Sputum viscosityForced expiratory volume in 1 second (FEV1)Mucociliary clearance rateBiofilm biomass

Beyond the preview

Go deeper on Disulfide bonds in mucin and bacterial biofilm extracellular matrix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Disulfide bonds in mucin and bacterial biofilm extracellular matrix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call